{
    "Trade/Device Name(s)": [
        "Yumizen C1200 ALP",
        "Yumizen C1200 Albumin"
    ],
    "Submitter Information": "HORIBA ABX SAS",
    "510(k) Number": "K191245",
    "Predicate Device Reference 510(k) Number(s)": [
        "K171080",
        "K060434"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CJE",
        "CIX"
    ],
    "Summary Letter Date": "July 18, 2019",
    "Summary Letter Received Date": "July 19, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1050",
        "21CFR862.1035"
    ],
    "Regulation Name(s)": [
        "Alkaline phosphatase or isoenzymes test system",
        "Albumin test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Alkaline Phosphatase",
        "Albumin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Yumizen C1200 Clinical Chemistry Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Kinetic photometric test (ALP)",
        "Colorimetry (Albumin)"
    ],
    "Methodologies": [
        "Quantitative in vitro diagnostic determination"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Yumizen C1200 ALP and Albumin reagents for quantitative measurement of alkaline phosphatase and albumin on the Yumizen C1200 analyzer",
    "Indications for Use Summary": "Yumizen C1200 ALP reagent is intended for quantitative determination of alkaline phosphatase in human serum and plasma; Yumizen C1200 Albumin reagent is intended for quantitative determination of albumin in human serum and plasma, aiding in diagnosis and treatment of diseases involving liver, bone, parathyroid, intestinal, or kidney function",
    "fda_folder": "Clinical Chemistry"
}